Neurochemical Research

, Volume 32, Issue 7, pp 1188–1195 | Cite as

Protective Effects of Lamotrigine, Aripiprazole and Escitalopram on Depression-induced Oxidative Stress in Rat Brain

  • İbrahim Eren
  • Mustafa NazıroğluEmail author
  • Arif Demirdaş
Original Paper


We investigated the effects of lamotrigine, aripiprazole and escitalopram administration and experimental depression on lipid peroxidation (LP) and antioxidant levels in cortex of the brain in rats. Forty male wistar rats were randomly divided into five groups. First group was used as control although second group was depression-induced group. Aripiprazole, lamotrigine and escitalopram per day were orally supplemented to chronic mild stress (CMS) depression-induced rats constituting the third, fourth and fifth groups for 28 days, respectively. Depression resulted in significant decrease in the glutathione peroxidase (GSH-Px) activity, reduced glutathione and vitamin C of cortex of the brain although their levels and beta-carotene concentrations were increased by the three drugs administrations to the animals of CMS induced depression group. The LP levels in the cortex of the brain and plasma of depression group were elevated although their levels were decreased by the administrations. The increases of antioxidant values in lamotrigine group were higher according to aripiprazole and escitalopram supplemented groups. Vitamin A level did not change in the five groups. In conclusion, the experimental depression is associated with elevated oxidative stress although treatment with lamotrigine has most protective effects on the oxidative stress within three medicines.


Lamotrigine  Depression Antioxidant Oxidative stress Selective-serotonin reuptake inhibitors 



Chronic mild stress


Glutathione peroxidase




Lipid peroxidation






Polyunsaturated fatty acids


Reactive oxygen species


Selective- serotonin reuptake inhibitors


Superoxide dismutase



Authors wish to thank A. Cihangir Uğuz and Ömer Çelik for excellent help on the analysis of antioxidant parameters.


  1. 1.
    Halliwell B, Gutteridge JMC (1999) Free radicals, other reactive species and disease. In: Halliwell B, Gutteridge JMC (eds) Free radicals in biology, medicine, 3rd edn. Oxford University Press, New York, pp 639–645Google Scholar
  2. 2.
    Nazıroğlu M, Şimşek M, Kutlu M (2004) Moderate exercise with dietary vitamin C and E combination protects streptozotocin- induced oxidative damage to the blood and improves fetal outcomes in pregnant rats. Clin Chem Lab Med 42:511–517PubMedCrossRefGoogle Scholar
  3. 3.
    Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O (2001) Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 64:43–51PubMedCrossRefGoogle Scholar
  4. 4.
    Takuma K, Baba A, Matsuda T (2004) Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol 72:111–127PubMedCrossRefGoogle Scholar
  5. 5.
    Whanger PD (2001) Selenium and the brain: a review. Nutr Neurosci 4:81–97PubMedGoogle Scholar
  6. 6.
    Thase ME (2005) Bipolar depression: issues in diagnosis and treatment. Harv Rev Psychiatry 13:257–271PubMedCrossRefGoogle Scholar
  7. 7.
    Maher P, Davis JB (1996) The role of monoamine metabolism in oxidative glutamate toxicity. J Neurosci 16:6394–6401PubMedGoogle Scholar
  8. 8.
    Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lonnqvist J (2004) Is low dietary intake of omega−3 fatty acids associated with depression? Am J Psychiatry 161:567–569PubMedCrossRefGoogle Scholar
  9. 9.
    Rao JS, Ertley RN, Lee HJ, Demar JC Jr, Arnold JT, Rapoport SI, Bazinet RP (2006). n-3 Polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol Psychiatry 12:36–46PubMedCrossRefGoogle Scholar
  10. 10.
    Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY (1999) Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 22:275–291CrossRefGoogle Scholar
  11. 11.
    Baydas G, Kutlu S, Nazıroğlu M, Canpolat S, Sandal S, Özcan M, Keleştimur H (2003) Inhibitory effects of melatonin on lipid peroxidation induced by intracerebroventricularly administered homocysteine. J Pineal Res 34:36–39PubMedCrossRefGoogle Scholar
  12. 12.
    Nazıroğlu M. (2006). Effects of physical exercise with a dietary vitamins C and E combination on oxidative stress in muscle, liver and brain of streptozotocin- induced diabetic pregnant rat. In: Braunstain MH (ed), Vitamin E: New Research. Nova Science Publishers Inc, NY USA, pp 69–83Google Scholar
  13. 13.
    Özmen I, Naziroglu M, Alici HA, Sahin F, Cengiz M, Eren I (2007) Spinal morphine administration reduces the fatty acid contents in spinal cord and brain by increasing oxidative stress. Neurochem Res 32:19–25PubMedCrossRefGoogle Scholar
  14. 14.
    Eren I, Nazıroğlu M, Demirdaş A, Çelik O, Uğuz AC, Altunbaşak A, Özmen I, Uz E (2007) Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat. Neurochem Res 32: (in press)Google Scholar
  15. 15.
    Cyranowski JM, Marsland AL, Bromberger JT, Whiteside TL, Chang Y, Matthews KA (2007) Depressive symptoms and production of proinflammatory cytokines by peripheral blood mononuclear cells stimulated in vitro. Brain Behav Immun 21:229–237PubMedCrossRefGoogle Scholar
  16. 16.
    Andreasson A, Arborelius L, Erlanson-Albertsson C, Lekander M. (2007) A putative role for cytokines in the impaired appetite in depression. Brain Behav Immun 21:147–152PubMedCrossRefGoogle Scholar
  17. 17.
    Kökçam İ, Nazıroğlu M (2002) Effects of vitamin E supplementation on blood antioxidants levels in patients with Behçet’s disease. Clin Biochem 35:633–639PubMedCrossRefGoogle Scholar
  18. 18.
    Chen F, Larsen MB, Sanchez C, Wiborg O (2005) The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism Comparison with other serotonin transporter inhibitors. Eur Neuropsychopharmacol 15:193–198PubMedCrossRefGoogle Scholar
  19. 19.
    Patkar AA, Peindl K, Mago R, Mannelli P, Masand PS (2006). An open-label, rater-blinded, augmentation study of aripiprazole in treatment-resistant depression. Prim Care Companion J Clin Psychiatry 8:82–87PubMedGoogle Scholar
  20. 20.
    Worthington JJ 3rd, Kinrys G, Wygant LE, Pollack MH. (2005). Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients. Int Clin Psychopharmacol 20:9–11PubMedCrossRefGoogle Scholar
  21. 21.
    Bourin M, Masse F, Hascoet M (2005) Evidence for the activity of lamotrigine at 5-HT(1A) receptors in the mouse forced swimming test. J Psychiatry Neurosci 30:275–282PubMedGoogle Scholar
  22. 22.
    Grippo AJ, Moffitt JA, Johnson AK (2002). Cardiovascular alterations and autonomic imbalance in an experimental model of depression. Am J Physiol Regul Integr Comp Physiol 282:R1333–R1341PubMedGoogle Scholar
  23. 23.
    Grippo AJ, Beltz TG, Johnson AK (2003) Behavioral and cardiovascular changes in the chronic mild stress model of depression. Physiol Behav 78:703–710PubMedCrossRefGoogle Scholar
  24. 24.
    Muscat R, Willner P (1992) Suppression of sucrose drinking by chronic mildunpredictable stress: a methodological analysis. Neurosci Biobehav Rev 16:507–517PubMedCrossRefGoogle Scholar
  25. 25.
    Placer ZA, Cushman L, Johnson BC (1966) Estimation of products of lipid peroxidation (malonyl dialdehyde) in biological fluids. Anal Biochem 16:359–364PubMedCrossRefGoogle Scholar
  26. 26.
    Sedlak J, Lindsay RHC (1968) Estimation of total, protein bound and non-protein sulfhydryl groups in tissue with Ellmann’ s reagent. Anal Biochem 25:192–205PubMedCrossRefGoogle Scholar
  27. 27.
    Lawrence RA, Burk RF (1976) Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 71:952–958PubMedCrossRefGoogle Scholar
  28. 28.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin-Phenol reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  29. 29.
    Suzuki J, Katoh N (1990) A simple and cheap method for measuring vitamin A in cattle using only a spectrophotometer. Jpn J Vet Sci 52:1282–1284Google Scholar
  30. 30.
    Jagota SK, Dani HM (1982) A new colorimetric technique for the estimation of vitamin C using Folin phenol reagent. Anal Biochem 127:178–182PubMedCrossRefGoogle Scholar
  31. 31.
    Sierra-Honigmann MR, Murphy PA. (1992) Suppression of interleukin−1 action by phospholipase-A2 inhibitors in helper T lymphocytes. Pept Res 5:258–261PubMedGoogle Scholar
  32. 32.
    Nunez MJ, Balboa J, Rodrigo E, Brenlla J, Gonzalez-Peteiro M, Freire-Garabal M (2006) Effects of fluoxetine on cellular immune response in stressed mice. Neurosci Lett 396:247–251PubMedCrossRefGoogle Scholar
  33. 33.
    Atmaca M, Tezcan E, Kuloglu M, Ustundag B, Tunckol H (2004) Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment. Eur Arch Psychiatry Clin Neurosci 254:231–235PubMedGoogle Scholar
  34. 34.
    Nieuwstraten C, Labiris NR, Holbrook A (2006) Systematic overview of drug interactions with antidepressant medications. Can J Psychiatry 51:300–316PubMedGoogle Scholar
  35. 35.
    Yamada M, Yamada M, Yamazaki S, Takahashi K, Nara K, Ozawa H, Yamada S, Kiuchi Y, Oguchi K, Kamijima K, Higuchi T, Momose K (2001) Induction of cysteine string protein after chronic antidepressant treatment in rat frontal cortex. Neurosci Lett 301:183–186PubMedCrossRefGoogle Scholar
  36. 36.
    Maes M, De Vos N, Pioli R, Demedts P, Wauters A, Neels H, Christophe A (2000) Lower serum vitamin E concentrations in major depression Another marker of lowered antioxidant defenses in that illness. J Affect Disord 58:241–246PubMedCrossRefGoogle Scholar
  37. 37.
    Muth EA, Haskins JT, Moyer JA, Husbands GE, Nielsen ST, Sigg EB (1986) Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol 35:4493–4497PubMedCrossRefGoogle Scholar
  38. 38.
    Czernichow S, Hercberg S (2001) Interventional studies concerning the role of antioxidant vitamins in cardiovascular diseases A review. J Nutr Health Aging 5:188–195PubMedGoogle Scholar
  39. 39.
    Bolden-Watson C, Richelson E (1993). Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 52:1023–1029PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • İbrahim Eren
    • 1
  • Mustafa Nazıroğlu
    • 2
    Email author
  • Arif Demirdaş
    • 1
  1. 1.Department of Psychiatry, Medical FacultySuleyman Demirel UniversityIspartaTurkey
  2. 2.Department of Biophysics, Medical FacultySuleyman Demirel UniversityIspartaTurkey

Personalised recommendations